The gross proceeds from the initial public offering are expected to be approximately $191 million, before deducting underwriting discounts and commissions and other offering expenses, and excluding ...

About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...

KRTL Holding Group, Inc. (OTC: KRTL) is strategically expanding its presence in the heart of South America, where biodiversity flourishes and untapped ...

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...

Chubb and Amica are among the best home insurance companies in California. Many, or all, of the products featured on this page are from our advertising partners who compensate us when you take ...

Soligenix, Inc. (NASDAQ: SNGX) decreased in price early Tuesday, as the late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its fourth quarter and full year 2024 ...

On December 2022, 42 companies have committed an investment Rs. 4,115 crore (US$ 502.95 million) comprising 28 MSMEs and 14 Non-MSMEs (eight domestic and seven global companies) approved under the PLI ...

It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.

Live webcasts of these presentations will be available in the Events and Presentations section of Olema's investor relations website at ir.olema.com . The webcasts will be archived for at least 30 ...

The glut of life science office and lab space in San Diego County rose to an all-time high in 2024 and it’s expected to ...

U.S. Rep. April McClain Delaney visited Kite, a biopharmaceutical company that uses cell therapy to treat cancer, in Urbana ...